Cohort*(n = 749) | Sample*(n = 216) | P | ||
---|---|---|---|---|
Age (year) | 60.13 (7.32) | 7.32 (60.23) | 0.86†| |
Age group | 50-59 years | 426 (56.88) | 121 (56.02) | |
≥ 60 years | 323 (43.12) | 95 (43.98) | 0.88‡ | |
Gender | Male | 401 (53.54) | 123 (56.94) | |
Female | 348 (46.46) | 93 (43.06) | 0.39‡ | |
Risk profile | Moderate | 211 (28.17) | 59 (27.31) | |
High | 538 (71.83) | 157 (72.69) | 0.86‡ | |
Follow-up (year) | 3.34 (1.28) | 3.55 (1.22) | 0.03 †| |
Outcome | EGC | 6 (0.8) | 1 (0.46) | |
Death | 7 (0.93) | 2 (0.93) | ||
Drop-out | 49 (6.54) | 8 (3.70) | ||
Survival | 687 (91.73) | 205 (94.91) | 0.47‡ | |
Incidence Rate‖ | 240 (108, 534) | 131 (18, 930) | 0.98 § | |
Death Rate‖ | 280 (133, 587) | 262 (66, 1048) | 0.978 § | |
Drop-out Rate‖ | 1959 (1481, 2592) | 1049 (524, 2097) | 0.831 § |